Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at an average US$29.59 for US$799K under a trading plan, leaving 115,743 shares. Filed Jul 2, 2026 (Form 4).

Sold
27,000 shares
Price
US$29.59 average (US$29.34 to US$30.25)
Value
US$799K
Holding after
115,743 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise27,000US$5.20142,743Direct
Jul 1, 2026Common StockSale19,629US$29.34123,114Direct
Jul 1, 2026Common StockSale7,371US$30.25115,743Direct

Source

View original at SEC

Related